Michael Rosman
Gastroenterology · New York, NYNPI 1710335773
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 389 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 19.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,839, more than ten times the $12 reported in 2022.
Across 389 payments — averaging $19.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- AbbVie$1K
- Johnson & Johnson$889
- Takeda Pharmaceuticals U.S.A., Inc.$585
- QOL Medical, LLC$565
- Pfizer$439
- plus $2K from 21 others
What the payments were for
- Food & beverage$7,429100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 97 | $1,450 |
| AbbVie | 85 | $1,390 |
| Johnson & Johnson | 52 | $889 |
| Takeda Pharmaceuticals U.S.A., Inc. | 28 | $585 |
| QOL Medical, LLC | 14 | $565 |
| Pfizer | 30 | $439 |
| Ardelyx, Inc. | 18 | $361 |
| Regeneron Healthcare Solutions, Inc. | 9 | $277 |
| Celltrion USA Inc. | 11 | $239 |
| Sanofi | 3 | $188 |
| Phathom Pharmaceuticals, Inc. | 7 | $186 |
| E.r. Squibb & Sons, L.L.C. | 1 | $140 |
| Lilly USA, LLC | 7 | $128 |
| Madrigal Pharmaceuticals | 2 | $85 |
| Aimmune Therapeutics, Inc. | 4 | $81 |
| Bristol Myers Squibb | 3 | $80 |
| Ironwood Pharmaceuticals, Inc | 5 | $80 |
| Ipsen Biopharmaceuticals, Inc | 3 | $60 |
| Gilead | 2 | $42 |
| LEO Pharma Inc. | 1 | $32 |
| Evoke Pharma, Inc. | 1 | $25 |
| Vibrant Gastro, Inc. | 1 | $25 |
| Galderma Laboratories, L.p. | 1 | $19 |
| Phadia US Inc. | 1 | $18 |
| Mayne Pharma Commercial LLC | 1 | $17 |
| Redhill Biopharma Inc. | 1 | $16 |
| Amgen | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,429 in reported general payments places this provider in the 75th percentile of 1,682 gastroenterology providers in New York.
Other gastroenterology in New York
- David Carr LockeNew York$2M
- Arthur KornbluthNew York$1.9M
- Sonal KumarNew York$1M
- David PoppersNew York$939K
- Ellen ScherlNew York$857K
- Bruce SandsNew York$810K
- Jean Frederick ColombelNew York$786K
- Seth GrossNew York$624K
- Caterina Oneto ArayaNew York$610K
- Dana LukinNew York$491K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.